drugset / Trial / NCT00266032

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

NCT00266032

Phase 3 Completed 1166 enrolled Bayer
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the study is to determine safety and efficacy of long-cycle regimens of an oral contraceptive.

Timeline

Start
2005-12
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject drospirenone Unknown 3 mg Oral
Subject ethinyl estradiol Small molecule 20 ug Oral

Indications

No indication recorded.